Table 2.
Study | kVp | mAs | #Scans | CTDIvol | Relative Dose |
---|---|---|---|---|---|
Normal-Dose I | 100 | 150 | 20 | 108.77 | 100% |
Low-Dose I | 100 | 17 | 5+20 | 17.90* | 16.5% |
Low-Dose II | 80 | 17 | 5+20 | 11.89* | 10.9% |
Normal-Dose II | 100 | 150 | 20 | 108.77 | 100% |
Study | kVp | mAs | #Scans | CTDIvol | Relative Dose |
---|---|---|---|---|---|
Normal-Dose I | 100 | 150 | 20 | 108.77 | 100% |
Low-Dose I | 100 | 17 | 5+20 | 17.90* | 16.5% |
Low-Dose II | 80 | 17 | 5+20 | 11.89* | 10.9% |
Normal-Dose II | 100 | 150 | 20 | 108.77 | 100% |